November 15-16
-
Novel approaches could open therapeutic avenues for inflammatory arthritis
Adam Mor, MD, PhD, Assistant Professor of Medicine and Pathology at New York University School of Medicine, will discuss the role of T cells in rheumatoid arthritis.
-
Systemic sclerosis patients often face gastrointestinal woes
Tracy M. Frech, MD, MS, director of the Systemic Sclerosis Clinic at the University of Utah and a rheumatologist in the Veterans Affairs Salt Lake City Health Care System, will lead the clinical symposium Systemic Sclerosis: Assessment and Treatment of Gastrointestinal Manifestations, which starts at…
-
Evolving evidence creates novel treatment opportunities in axial spondyloarthritis
Dirk Elewaut, MD, PhD, Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology at Ghent University Hospital, Belgium, will discuss the role of the interleukin 23/interleukin 17 (IL23/IL17) axis in the pathogenesis of axial spondyloarthritis.